Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mean desaturation nadir values in children with sleep disordered breathing.

Archives of disease in childhood·2026
Same author

Towards Evidence-Based Vital Sign Reference Ranges: Centile Charts From Discharge Data in a UK Paediatric Hospital.

Nursing in critical care·2026
Same author

The Use of Diuretics in Infants with Established or Evolving Bronchopulmonary Dysplasia and Its Impact on the Duration of Home Oxygen Therapy.

Thoracic research and practice·2024
Same author

Retrospective review of treatment outcomes and costs in children with sleep disordered breathing assessed with multi-channel studies.

Sleep medicine: X·2024
Same author

Prospective evaluation of the impact of multi-channel studies on treatment outcomes in children with sleep disordered breathing.

Sleep medicine: X·2024
Same author

Considerations for the use of inhaled antibiotics for <i>Pseudomonas aeruginosa</i> in people with cystic fibrosis receiving CFTR modulator therapy.

BMJ open respiratory research·2024

Related Experiment Video

Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumonia in the developed world.

Andrew Prayle1, Maria Atkinson, Alan Smyth

  • 1University of Nottingham, Child Health, E Floor East Block, Queens Medical Centre, Nottingham, NG7 2UH. Alan.Smyth@nottingham.ac.uk

Paediatric Respiratory Reviews
|December 22, 2010
PubMed
Summary

This review highlights the management of childhood pneumonia in developed countries, emphasizing early assessment and antibiotics for moderate cases. It identifies evidence gaps and emerging pathogens, stressing the need for further clinical research.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Experiment Videos

Last Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pneumonia is a common childhood illness in developed nations, particularly affecting those under five.
  • Diagnosis relies on clinical symptoms and chest X-rays, with viral causes prevalent.
  • Microbiological diagnosis is often challenging due to insensitive tests.

Purpose of the Study:

  • To review current literature on childhood pneumonia management in developed countries.
  • To identify challenges in diagnosis and treatment.
  • To highlight emerging pathogens and antimicrobial resistance concerns.

Main Methods:

  • Comprehensive literature review of clinical trials and observational studies.
  • Analysis of diagnostic criteria and treatment strategies.
  • Discussion of etiological factors and pathogen prevalence.

Main Results:

  • Moderate pneumonia management focuses on clinical assessment, oral antibiotics, and early discharge.
  • Many clinical trials lack adequate power for definitive conclusions.
  • Emerging pathogens like antibiotic-resistant S. pneumoniae and novel viruses are significant.

Conclusions:

  • Evidence gaps exist in pneumonia management, necessitating further research.
  • Clinical judgment is crucial for managing complex cases.
  • Long-term effects and antimicrobial resistance require ongoing attention.